NewsRx

Search our medical news database

AMDL, Inc.

Cancer diagnostics company reports 101% increase in revenue

Published in Healthcare Mergers, Acquisitions and Ventures Week, May 1st, 2004

AMDL, Inc., (ADL) developer and marketer of tests for the early detection of cancer and other serious diseases, reported its fiscal 2003 financial results.

AMDL's product revenues for the year ended December 31, 2003, totaled $360,000, a 101.2% increase compared to product revenues of $179,000 for the year ended December 31, 2002.

Net loss for fiscal 2003 was $2.9 million or ($0.23) per share compared to a net loss of $3.6 million, or ($0.42) per share, for the year ended December 31, 2002.

"The company's primary objective remains receiving U.S. Food and Drug Administration clearance to market its DR-70 test in the U.S. FDA...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook